sur VALBIOTIS (EPA:ALVAL)
VALBIOTIS SA: Monthly update on voting rights and share capital
VALBIOTIS SA, based in Périgny, has published its monthly update in accordance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. As of March 31, 2025, the total number of shares comprising the share capital amounts to 15,794,596. The total number of theoretical voting rights is 16,486,754, while the number of exercisable voting rights reaches 16,450,649, after deduction of treasury shares.
The company reiterates Article 10.5 of its articles of association regarding threshold crossings. Any holder of 5% or more of the capital must notify the company, failing which they will lose their voting rights for these shares if they fail to comply.
VALBIOTIS, listed on Euronext Growth Paris, specializes in the design of innovative dietary supplements for cardiometabolic well-being. The company is a member of the BPI Excellence network and receives financial support from the European Union.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de VALBIOTIS